Bionova Scientific, is a biologics CDMO focused on the development and production of recombinant protein therapeutics, chiefly monoclonal antibodies, bispecifics, ADCs, fusion proteins and other complex biologics. We have a track record of successfully helping clients tackle challenges with products that are difficult to express and purify.
Our clients value our unique blend of technical strength and infrastructure combined with a flexible, client-first company culture. Our new state-of-the-art, commercial-ready GMP biologics manufacturing facility is on-track for commissioning next month, with capacity for 1000L cell culture (with expansion to 2 x 2000L as we ramp up production).
We offer a full range of CDMO services including cell line development, upstream and downstream process development, protein production, formulation development and more.